0001615774-16-008920.txt : 20161215 0001615774-16-008920.hdr.sgml : 20161215 20161214175431 ACCESSION NUMBER: 0001615774-16-008920 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161215 DATE AS OF CHANGE: 20161214 EFFECTIVENESS DATE: 20161215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc. CENTRAL INDEX KEY: 0001561551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990376434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-276313 FILM NUMBER: 162051938 BUSINESS ADDRESS: STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 674-1865 MAIL ADDRESS: STREET 1: 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: CERULEAN GROUP, INC. DATE OF NAME CHANGE: 20121102 D 1 primary_doc.xml X0707 D LIVE 0001561551 Enumeral Biomedical Holdings, Inc. 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA MASSACHUSETTS 02140 617-945-9146 DELAWARE Cerulean Group, Inc. CERULEAN GROUP, INC. Corporation true 2012 Wael Fayad 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Kevin G. Sarney 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Executive Officer Barry Buckland, Ph.D. 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Director Robert J. Easton 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Director Allan P. Rothstein 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Director Paul J. Sekhri 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Director Robert L. Van Nostrand 200 CambridgePark Drive, Suite 2000 Cambridge MA MASSACHUSETTS 02140 Director Pharmaceuticals Decline to Disclose 06b false 2016-12-09 false true true false 0 Katalyst Securities LLC 112494 None None 15 MAIDEN LANE, ROOM 601 NEW YORK NY NEW YORK 10038 CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA KY KENTUCKY MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NE NEBRASKA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA TX TEXAS WI WISCONSIN false 10774755 3431500 7343255 Pursuant to the issuer warrant tender offer, an aggregate of 6,863,000 Original Warrants were tendered and exercised. false 108 255000 0 Cash compensation equal to 8% of the cash exercise prices paid by holders in the issuer warrant tender offer. 0 true Enumeral Biomedical Holdings, Inc. /s/ Kevin G. Sarney Kevin G. Sarney Vice President of Finance 2016-12-14